Method of diagnosing alzheimer's disease and senile dementia

Details Method of diagnosing alzheimer's disease and senile dementia Method of diagnosing alzheimer's disease and senile dementia

1989-12-04

1991-05-21

Wax, Robert A.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

435 2, 435 3, 435 29, 424 9, H01H 5500, H01H 5300, H01F 718

Patent

active

050174703

ABSTRACT:
A method of treating humans suffering from central nervous system diseases, such as Alzheimer's disease, Parkinson's disease, senile dementia. The treatment consists of inducing into the patient's blood stream at least one from the group consisting of: sex hormones and anabolic hormones. Growth hormone is also be used in those patients in advanced stages of the disease, or in those patients where it has been determined that a low level of growth hormone is present. A method of diagnosing Alzheimer's disease, senile dementia, by the determination of the levels of the hormones somatotropin (human growth hormone) and somatomedin-C (IGF-I) after the administration of the Aroonsakul-Allen provocative test is also disclosed. Blood-sera samples are taken at certain time periods after the administration of L-Dopa, and the samples are tested for the levels of these hormones. These levels are then compared against the levels for normal subjects.

REFERENCES:
patent: 4699875 (1987-10-01), Appel
patent: 4701407 (1987-10-01), Appel

Affiliated with

Also associated with

Rating

Method of diagnosing alzheimer's disease and senile dementia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of diagnosing alzheimer's disease and senile dementia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing alzheimer's disease and senile dementia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-237688